Next Article in Journal
Sensing of p53 and EGFR Biomarkers Using High Efficiency SERS Substrates
Next Article in Special Issue
Microfluidic Impedimetric Cell Regeneration Assay to Monitor the Enhanced Cytotoxic Effect of Nanomaterial Perfusion
Previous Article in Journal
In Vivo Electrochemical Analysis of a PEDOT/MWCNT Neural Electrode Coating
Previous Article in Special Issue
Design and Characterization of a Sensorized Microfluidic Cell-Culture System with Electro-Thermal Micro-Pumps and Sensors for Cell Adhesion, Oxygen, and pH on a Glass Chip
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biosensors
Volume 5
Issue 4
10.3390/bios5040647
biosensors-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Biocompatible Hydrogels for Microarray Cell Printing and Encapsulation

by
Akshata Datar
†,
Pranav Joshi
† and
Moo-Yeal Lee
*
Department of Chemical & Biomedical Engineering, Cleveland State University, 1960 East 24th Street Cleveland, OH 44115-2214, USA
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Biosensors 2015, 5(4), 647-663; https://doi.org/10.3390/bios5040647
Submission received: 28 September 2015 / Revised: 21 October 2015 / Accepted: 22 October 2015 / Published: 26 October 2015
(This article belongs to the Special Issue Cell and Organ on Chip: Challenges and Advances)
Browse Figures
Versions Notes

Abstract

:
Conventional drug screening processes are a time-consuming and expensive endeavor, but highly rewarding when they are successful. To identify promising lead compounds, millions of compounds are traditionally screened against therapeutic targets on human cells grown on the surface of 96-wells. These two-dimensional (2D) cell monolayers are physiologically irrelevant, thus, often providing false-positive or false-negative results, when compared to cells grown in three-dimensional (3D) structures such as hydrogel droplets. However, 3D cell culture systems are not easily amenable to high-throughput screening (HTS), thus inherently low throughput, and requiring relatively large volume for cell-based assays. In addition, it is difficult to control cellular microenvironments and hard to obtain reliable cell images due to focus position and transparency issues. To overcome these problems, miniaturized 3D cell cultures in hydrogels were developed via cell printing techniques where cell spots in hydrogels can be arrayed on the surface of glass slides or plastic chips by microarray spotters and cultured in growth media to form cells encapsulated 3D droplets for various cell-based assays. These approaches can dramatically reduce assay volume, provide accurate control over cellular microenvironments, and allow us to obtain clear 3D cell images for high-content imaging (HCI). In this review, several hydrogels that are compatible to microarray printing robots are discussed for miniaturized 3D cell cultures.

1. Introduction

In the process of drug discovery, great importance is given to high-throughput, in vitro cell-based assays with the capability of high-content imaging (HCI) [1]. Conventional cell monolayers cultured on the surface of 96-wells (also known as, 2D cell monolayer cultures) have been widely used as a gold standard for cellular in vitro models in high-throughput screening (HTS) of compounds. However, 2D cell monolayer cultures may not accurately mimic physiological properties of tissues in vivo, thus providing limited predictability of drug responses [2]. To address this issue and better mimic cellular microenvironments in tissues, three-dimensional (3D) cell cultures have been adopted in preclinical evaluations of drug candidates. These have several advantages over the conventional 2D cultures, including in-vivo-like cell morphology with cell-cell and cell-extracellular matrix (ECM) interactions and physiologically-relevant gene/protein expression [3,4]. Although there have been several methods developed to grow cells in 3D, including microbeads, 3D scaffolds, cells encapsulated in hydrogels, and hanging droplets [4,5,6,7], in this review we focus on miniaturized 3D cell cultures in hydrogels that are compatible with microarray bioprinting.
Microarray bioprinting refers to printing cells encapsulated in hydrogels in a spatially addressable manner using automated liquid dispensing robots such as microarray spotters. Cells in nano-liter volume (as small as 30–60 nL) can be dispensed onto functionalized glass slides or micropillar/microwell chip platforms and grown in growth media to support miniaturized 3D cell cultures for toxicology assays [8,9]. For example, cells in hydrogels can be spotted or printed on top of the micropillars and immersed into the microwells containing growth media for miniaturized 3D cell cultures. The microwell chip can accommodate up to 950 nL of compounds, recombinant viruses, growth factors, and fluorescent dyes for various cell-based assays. Since the micropillar chip is complementary to the microwell chip, cells on the micropillars can be exposed to hundreds of different test conditions in the microwells simultaneously by simply sandwiching the two chips together [9]. The cells on the micropillar chip can be exposed to compounds for a period of time and stained with fluorescent dyes or fluorescently labeled antibodies to assess drug efficacy and toxicity [9]. Compared to traditional 2D cell monolayer cultures, microarray bioprinting offers several attractive features, including physiologically relevant cells grown in 3D, miniaturization of cell-based assays saving valuable raw materials, such as primary human cells obtained from patients, and ultrahigh-throughput capability of testing cell culture conditions [10].
In this review, we address the fundamental principles of microarray bioprinting, the roles of hydrogels for cell encapsulation, the properties of hydrogels required for microarray bioprinting, and a few examples of hydrogels that can meet the requirements.

2. Microarray Bioprinting Technology

To encapsulate cells in 3D and prevent their direct contact with the surface, polymeric substances (hydrogels) that have capacity to hold a large amount of water and show compatibility to cells have been employed in microarray bioprinting. Hydrogels can contain growth media and growth factors to support cell growth for 3D cell cultures and various other applications [11,12]. These cells in hydrogels can be dispensed on glass slides or plastic chips via several printing technologies, including micro-solenoid valves, piezoelectric nozzles, and laser-induced forward transfer (LIFT) technique, and acoustic bioprinting [13]. Among these, micro-solenoid valves (Figure 1A) working on the principle of electromagnetic induction are the most commonly used for cell printing due to their robust and reliable printing with cells in hydrogels [8]. A micro-solenoid valve consists of a metal rod within solenoid coils that moves up and down by electric voltages applied, acting as a gate to dispense cells in hydrogels. The intensity and duration of voltage applied to the micro-solenoid valve control the open time of the gate and hence determine the volume of biological samples dispensed. Certain pressure is applied to maintain the liquid sample to move forward when the gate is opened; typically syringe pumps are necessary to maintain the pressure and dispense cells in hydrogels. The solenoid valves allow us to print relatively high density of cells in hydrogels and accommodate relatively viscous samples. However, the dispensing volume is large, ranging from 20 to 1000 nL, compared to piezoelectric nozzles. The principle behind piezoelectric nozzles (Figure 1B) is very similar to the conventional inkjet printers [14]. The piezoelectric transducer in the nozzle contracts and expands with application of certain voltages, which pushes biological samples including cells in hydrogels to flow [15]. The volume dispensed depends on the voltage and frequency applied, viscosity of hydrogels, and the diameter of the nozzle, making the dispensing volume extremely small, ranging from 50 to 1000 pL. However, piezoelectric printing is significantly influenced by viscosity of the samples, and the nozzles are frequently clogged with cells. Thermal inkjet printers can be used to print cells in hydrogels in a high throughput fashion and may reduce the tip clogging issue considerably by heating polymers and making them less viscous. However, thermal inkjet printing may not be suitable for cell printing due to cell damage or death by high temperature [16]. Another printing technology that can be used for microarray bioprinting is laser-induced forward transfer (LIFT) (Figure 1C). In this technique, a donor film and an acceptor film are set in a parallel manner, where the donor film is a thin film made of cells in hydrogel to be printed. A laser beam is shone on the absorbing substrate layer, which develops laser-induced vapor bubbles, inducing deposition of cell spots on the acceptor film that is either cell culture media or biopolymer-coated glass slides [13,15,17]. Interestingly, the volume of the cell droplets dispensed using this technique is varied, depending on the temperature applied, the nature of biological samples, and the thickness of the donor film containing cells [15,18]. With appropriate optimization of laser beam intensity and focusing conditions, the LIFT technology has been applied for printing DNA, proteins, peptides, and cells in microarrays [14,19]. Although LIFT can be used to print a wide range of biological samples, cell printing in hydrogels with LIFT might be challenging due to high temperature induced by the laser beam. Therefore, maintaining high cell viability and proliferation after printing would be a concern [20,21]. As the dispensed volume depends on the thickness of the hydrogel layer, the uniformity of cell seeding and cell distribution over the glass slide have to be investigated and validated prior to data analysis with test compounds. Acoustic printers depend on ultrasound for printing cells in hydrogels (Figure 1D). A high-intensity acoustic wave is generated by focusing ultrasound beams, and this energy is used to dispense liquid droplets from air-liquid interface. This technique was initially developed for printing single cells in pico-liter droplets. However, modification and optimization have enabled the implementation of 3D cell cultures [22,23]. Characteristics of bioprinting methods are summarized in Table 1. Cell printing using acoustic printers may be questionable as cell membrane might be affected and ruptured when the cells are exposed to ultrasonic waves and, hence, this technique is considered unsuitable for this application [24].
Biosensors 05 00647 g001 1024
Figure 1. Various mechanisms for printing biological samples: (A) Micro-solenoid valve using electromagnetic induction; (B) Piezoelectric nozzle using piezoelectric vibration; (C) Laser-induced forward transfer (LIFT) using a laser beam to propel cell spots [13], and (D) Acoustic wave generator using ultrasound to produce acoustic waves for cell printing (Reproduced from Reference [23] with permission of The Royal Society of Chemistry).
Figure 1. Various mechanisms for printing biological samples: (A) Micro-solenoid valve using electromagnetic induction; (B) Piezoelectric nozzle using piezoelectric vibration; (C) Laser-induced forward transfer (LIFT) using a laser beam to propel cell spots [13], and (D) Acoustic wave generator using ultrasound to produce acoustic waves for cell printing (Reproduced from Reference [23] with permission of The Royal Society of Chemistry).
Biosensors 05 00647 g001
Table
Table 1. Comparison of typical microarray bioprinting methods.
Table 1. Comparison of typical microarray bioprinting methods.
Printing MechanismsCell ViabilityHydrogels PrintedCells PrintedSpot Volume (nL)References
Micro-Solenoid Valve>95%Alginate, polyvinyl alcohol, PuraMatrix™, Matrigel®Hela cell line, human glioblastoma, hepatoma cell lines20–1000[8,9,14,25,26]
Piezoelectric Nozzle95%Polyethylene glycol diacrylate (PEG-DA), methacrylated gelatinHuman fibroblasts, chondrocytes, HepG20.05–1[13,14,27,28]
LIFT>90%Gelatin, Matrigel®Human mesenchymal stem cells, keratinocytes0.1[13,27,29]
Ultrasonic Wave Generator85%–89%Dextran, polyethylene glycol (PEG)Mouse myofibroblasts, embryonic stem cells, breast cancer cell lines, cardiomyocytes40–300[12,22]
Several micro-solenoid valves or piezoelectric nozzles are mounted on a robotic arm that moves along X, Y, and Z axis and works simultaneously to print biological samples, which is called a microarray spotter [30]. There are several clear advantages of using the microarray spotter, including its accurate printing of very small volumes of biological samples such as cells in hydrogels, growth media, growth factors, recombinant viruses, proteins, and DNAs. In addition, it can reduce manual intervention by controlling cell dispensing with a computer in high throughput. Preventing evaporation of water in extremely small droplets can be done with surface chilling and condensation, and high speed printing [5,9,14]. However, there are several drawbacks in the microarray spotters. The printing tips can be easily clogged when big particles (e.g., microbial strains) are printed or highly viscous hydrogels are used to encapsulate cells [9]. To minimize the clogging issues, cells have to be well suspended in hydrogels immediately before printing, and a proper seeding density of cells has to be tested and used. Furthermore, rapid gelation of hydrogels within micro-solenoid valves, piezoelectric nozzles, ceramic printing tips, and tubing have to be avoided. Thus, it is extremely critical to understand the mechanisms of hydrogel gelation and optimum conditions used prior to cell printing using the microarray spotter [9,31,32]. The criteria of hydrogel selection are primarily based on the mechanism of gelation, compatibility with cells, and microarray spotters used. Several applications of the microarray bioprinting technology have been demonstrated, which include high-throughput assessment of metabolism-induced toxicity [8], screening of anticancer drugs [9], stem cell differentiation [33], and miniaturized tissue engineering by layer-by-layer cell printing [34].

3. Factors to be Considered When Selecting Hydrogels for Microarray Bioprinting

When selecting hydrogels for microarray bioprinting, several critical factors such as gelation mechanism, compatibility with surface, and biocompatibility have to be considered. The mechanism of gelation is one of the most important aspects of hydrogels for successful microarray bioprinting [35]. Without complete understanding of the gelation mechanism, it is difficult to assess feasibility of hydrogels for printing. In general, temperature-sensitive hydrogels, such as Matrigel®, require micro-solenoid valves and tubing to be chilled to avoid spontaneous gelation within the system at room temperature. Once gelation takes place in micro-solenoid valves, it is almost impossible to remove the hydrogel from the valves. Thus, gelation of hydrogel by ionic crosslinking [36], photo-polymerization [37], biocatalysis [38], covalent bonding [39], or pH-induced phase transition [38] would be better suited for cell encapsulation in microarray bioprinting [40]. Typically, gelation of hydrogels with cells on a glass slide or a plastic chip takes place by printing two components necessary for gelation sequentially. For example, barium chloride or calcium chloride that is commonly used to crosslink alginate is printed on top of micropillars, which is followed by printing alginate mixed with cells on the surface of the salt to initiate gelation [8,41]. This approach is simple and ideally suited to minimize unwanted gelation in micro-solenoid valves and remove remaining hydrogels by rinsing with water. One of the drawbacks of these types of ionic hydrogels is that they degrade slowly over time by chelating ions such as phosphate ions in growth media. UV irradiation on photo initiators combined with hydrogels can cause phase transition and be used to encapsulate cells [42,43]. However, long-term irradiation of UV can affect the viability of cells encapsulated on the glass slide [43,44]. Covalent crosslinking by radical reactions can be employed for microarray bioprinting as well. However, these chemicals can be toxic to the cells [31,42]. In addition, surface charge of hydrogels is an important factor to avoid ionic interactions between compounds and hydrogels used. Negatively or positively charged compounds can interact with certain functional groups (e.g., –COOH group to –NH2 group) on hydrogels and even adsorbed to hydrogels or the surface of a functionalized glass slide. There has been no universal hydrogel developed yet that can be used for all types of cells because each hydrogel has different cyto-compatibility and mechanisms of gelation.
In addition to the mechanism of gelation and biocompatibility, the interaction between the hydrogel used for cell encapsulation and the surface where the cell spots are attached becomes critical, to avoid detachment of the cell spots from the surface. For example, cell spots can be encapsulated in alginate and attached on the surface of the micropillar chip through polystyrene-co-maleic anhydride (PS-MA), poly-L-lysine (PLL), and alginate interactions (Figure 2) [8]. The micropillar chip made of polystyrene is hydrophobic, which makes the surface incompatible with hydrophilic hydrogel spots. Thus, the micropillar chip requires coating with an amphiphilic functional polymer, such as PS-MA, that is strongly attached on the surface of polystyrene through hydrophobic interactions. PLL is dispensed on the PS-MA coating to enhance cell spot attachment. Due to reactivity of maleic anhydride to amine groups on PLL, PLL printed on the tip of the micropillars can be covalently attached. Finally, PLL can interact with negatively charged alginate spots with cells due to positive charges remaining on PLL [8]. Alginate with cells can form a gel with barium chloride printed with PLL on the chip. Additionally, physicochemical interactions between printed biomaterials and the chip surface is another factor to consider. For example, thrombin that is printed on the micropillar chip to initiate gelation of fibrin gel can be denatured on the hydrophobic nature of the chip surface [45]. Thus, changing the surface property to hydrophilic by coating or printing hydrophilic biopolymers would be critical to minimize denaturation of thrombin.
Biosensors 05 00647 g002 1024
Figure 2. Chemical and ionic interactions among polystyrene-co-maleic anhydride (PS-MA), poly-l-lysine (PLL), and alginate that support cell spots to adhere to the surface of the micropillar chip.
Figure 2. Chemical and ionic interactions among polystyrene-co-maleic anhydride (PS-MA), poly-l-lysine (PLL), and alginate that support cell spots to adhere to the surface of the micropillar chip.
Biosensors 05 00647 g002
The ability to manipulate cellular microenvironments becomes critically important in miniaturized 3D cell cultures, which include the specific arrangement of cell types, composition of extracellular matrices (ECMs), gradients of soluble factors (growth and differentiation factors), and cell encapsulation materials (natural hydrogels and synthetic polymers) [43,46]. In particular, additives in hydrogels such as ECMs, including elastin, collagen, fibronectin, proteoglycans, laminin and hyaluronic acid can influence cell viability, proliferation and differentiation by controlling signaling pathways in the cells [47]. The ECM-cell interactions are required to better mimic 3D microenvironments [35]. Thus, hydrogels selected for cell encapsulation have to be compatible with ECMs as well. Some highly charged hydrogels tend to be precipitated when mixed with ECMs, which are unsuited for microarray bioprinting.
Mechanical stability over time as well as transparency of hydrogels have to be considered for microarray bioprinting to obtain proper cell images from staining with fluorescent dyes or fluorescently-labeled antibodies [48,49]. Mammalian cells encapsulated in hydrogels tend to secrete matrix metalloproteinases (MMPs) over time to get accustomed to a new microenvironment [50,51]. These MMPs can degrade protein/peptide-based hydrogels and weaken mechanical stability of hydrogels resulting in cell spot detachment during incubation or cell staining. Therefore, degradable hydrogels such as Matrigel® and PuraMatrix™ have to be mixed with non-degradable hydrogels, such as alginate, when cells are cultured long-term. In addition, transparency of hydrogels is important for high-content cell imaging to minimize auto-fluorescence. Unlike applications of hydrogels in tissue engineering [45], swelling of hydrogels is not a concern due to small volume of cell spots printed.

4. Potential Hydrogels for Microarray Cell Printing and Encapsulation

Based on their origin, hydrogels are classified into natural and synthetic polymers [52,53]. Natural hydrogels include alginate, collagen, Matrigel®, fibrin, agarose, and gelatin among others. Synthetic hydrogels include polyethylene glycol (PEG), polyvinyl alcohol (PVA), polyacrylate, and polyurethane [54], which are usually preferred when increased mechanical strength is required [52,55,56]. A few examples of hydrogels that have been used for microarray cell printing and those we think can be potentially used for cell encapsulation on the chip are discussed.

4.1. Natural Hydrogels

4.1.1. Alginate

Alginate is a natural polymer derived from brown sea weed, and has been widely used in tissue engineering applications due to its biocompatibility, availability, and low cost [41]. Negatively charged alginate forms a transparent gel with divalent cations such as Ba2+, Ca2+, and Mg2+ via ionic crosslinking [8]. Its applications include encapsulation of human embryonic stem cells (hESCs), bone tissue regeneration, development of liver cell models, and drug efficacy/toxicity testing [57,58,59]. Cells encapsulated in alginate have shown good viability due to diffusion of nutrients and gases through the alginate gel and nontoxic nature of the alginate matrix to cells [60]. Alginate stands out as a good hydrogel as it supports cell growth and proliferation and is potentially non-toxic. Although alginate is easy to print at low concentrations (e.g., 1%) and non-degradable by MMPs, there are several limitations that might prevent its wide range of use. For example, high concentrations of divalent cations used for its gelation can be toxic to cells, thus necessitating the cells rinsed with growth media after encapsulation. Alginate is susceptible to degradation by chelating agents, leading to mechanical instability over time. In addition, alginate does not support viral transduction of cells due to high affinity of recombinant viruses to the alginate matrix [26,31,41]. Efforts have been made to make alginate non-degradable by chemical modification with methacrylate, which make alginate photo-crosslinkable while maintaining low cytotoxicity, and hence a reliable hydrogel for cell encapsulation [42]. Although alginate is widely used for cell encapsulation in vitro, there is no interaction between cells and alginate matrix, causing retarded cell growth or death [61]. Alginate may also cause inflammatory responses in the presence of immune cells, which can limit the applications of alginate-based cell encapsulation in vivo [62].

4.1.2. Matrigel®

Matrigel® is a mixture of basement membrane proteins extracted from Engelbreth-Holm Swarm (EHS) mouse sarcoma cells, consisting of laminin, collagen IV, entactin, and heparin sulfate proteoglycan along with various growth factors [63]. Since it resembles complex cellular microenvironments found in many tissues, it has been widely used in cell growth, differentiation, angiogenesis, and tissue vascularization [64,65]. Unlike alginate, Matrigel® is a temperature sensitive hydrogel which forms a transparent gel at a temperature ranging from 24 to 37 °C, with the speed of gelation being dependent on concentration and incubation temperature [66]. The mechanical properties of Matrigel® can be enhanced by glutaraldehyde crosslinking [45]. For microarray printing, cells are mixed with cold Matrigel® on ice and then printed immediately while maintaining the dispensing head and tubing below 9 °C. Printed cell spots on the chip is gelled at 37 °C in a humid incubation chamber. Printing Matrigel® requires repeated rinsing of tubing with cold water to maintain low temperature and prevent undesirable gelation in the tubing, which is cumbersome and difficult. Another limitation of Matrigel® comes from batch-to-batch variations in its compositions due to differences in the size of tumor and tissue preparation, which greatly affect reliability and reproducibility of experimental outcomes. Due to this variation, some batches of Matrigel® tend to form a gel quicker than the others [63,66]. Finally, unidentified growth factors included in Matrigel® can influence cell differentiation, which limits the use of Matrigel® for stem cell research.

4.1.3. Fibrin

Fibrinogen is a large and complex glycoprotein that is converted into fibrin due to thrombin driven polymerization during blood clot formation [52]. Fibrin gel has been widely used in gene delivery, cell growth and differentiation, and tissue engineering to fill bone cavities and repair neurons, heart valves, vascular grafts, and the surface of the eye [47,57,67,68]. The rate of gelation is strongly influenced by the concentration of fibrinogen and the activity of thrombin. For microarray bioprinting, thrombin is printed on the surface of the micropillar chip first, and then a mixture of cells and fibrinogen is printed on top of thrombin spots. Thrombin initiates polymerization of fibrinogen on the chip, forming a transparent gel with cells. However, the transparency of the gel depends on the concentration of fibrinogen and thrombin used [67]. Similar to Matrigel®, fibrin gel can be degraded by proteolytic enzymes such as MMPs, which may lead to instability of gel structures over time. To minimize or control degradation of fibrin gel, proteinase inhibitors, such as aprotinin, are added in growth media [67,69]. In addition, the mechanical strength of fibrin gel can be enhanced by supplementing Ca2+ ions [57].

4.1.4. Collagen

Collagen is the main structural protein found in various connective tissues and the most abundant protein in mammals [70]. Among various types of collagen found, type I collagen is the most commonly used for 3D cell cultures in tissue engineering [41,65,71]. In addition, type IV collagen found in Matrigel® provides structural support to the matrix and assembles other basement membrane components through interactions. Collagen spontaneously forms a triple helix scaffold at neutral pH and 37 °C, leading to gelation [72]. Although collagen is one of the most well-known and biocompatible hydrogels, it is easily broken down by collagenases and other proteolytic enzymes secreted by cells [4,71]. Since collagen is a temperature sensitive hydrogel, the protocol for microarray printing is similar to that of Matrigel® and share the same limitations [3,63,73].

4.1.5. Hyaluronic Acid

Hyaluronic acid (HA) is an anionic, non-sulfated glycosaminoglycan commonly found in connective, epithelial, and neural tissues. Because of its common presence in ECMs and influence in signaling pathways through interactions with cell surface receptors, hyaluronic acid has been widely used as a scaffold material in tissue engineering and regenerative medicine, in particular for stem cell differentiation, wound healing, and angiogenesis [35]. However, hyaluronic acid typically shows poor mechanical strength and can be broken down by hyaluronidases, thus requires crosslinking with chemical functional groups [35]. For example, thiol groups for Extracel and HyStem, hexadecylamide for Hymovis, tyramine for Corgel, formaldehyde for Hylan-A, and divinylsulfone for Hylan-B have been attached on hyaluronic acid for gelation [74,75]. Extracel is a mixture of Gelin-S, Glycosil, and Extralink in 2:2:1 ratio [43], among which Glycosil is thiol-modified hyaluronic acid and Gelin-S is thiol-modified gelatin. Extralink is a chemical cross linker, which can influence viscosity of Extracel through crosslinking. The mixture of Glycosil and Extralink alone can form a gel, but Gelin-S is added to enhance the viability of the cells encapsulated in Extracel [43,76]. Corgel is another hyaluronic acid-derived hydrogel, and gelation occurs due to crosslinking of tyramine-functionalized HA in the presence of peroxidases [75]. Corgel has been used for tissue regeneration in rat models [77]. To further enhance its biocompatibility, hyaluronic acid has been combined with fibronectin for culturing endothelial cells in wound healing and angiogenesis [37]. These hybrid hydrogels are used to encapsulate chondrocytes, adipocyte stem cells, and mesenchymal stem cells (MSCs) as well [43,78]. High viscosity of hyaluronic acid may cause clogging of tips or solenoid valves in microarray spotters. Similar to alginate, it is not very cell adhesive, thus requiring further chemical modification to provide cell-matrix interactions [52].

4.2. Synthetic Hydrogels

4.2.1. PuraMatrix™

PuraMatrix™ is a biocompatible, synthetic peptide, which is self-assembled when mixed with small amounts of salts in cell culture media and form a transparent gel [79]. It mimics natural ECMs and allows cell proliferation in 3D cultures. In addition to this it is known for neurite outgrowth, active synaptic formation and maintaining embryonic stem cells undifferentiated [79]. It is stable at wide ranges of temperature and pH and supports the growth of various cells in tissue engineering scaffolds [36]. For microarray bioprinting, cells have to be rinsed with 10% sucrose and then pelleted by centrifugation to remove salts in cell suspension. Various salt solutions can be printed first on the chip to initiate gelation, which is followed by printing a mixture of PuraMatrix™ and sucrose-rinsed cell pellets. Cell pellets have to be handled gently to avoid cell membrane rupture when mixing with PuraMatrix™. One of critical limitations of PuraMatrix™ is its low pH [79], which is harmful to many cells, leading to low cell viability after encapsulation. Thus, the mixture of PuraMatrix™ and cells has to be printed quickly and rinsed with growth media to neutralize pH [76]. This cumbersome handling and medium changing increase the risk of cell contamination.

4.2.2. Polyethylene Glycol (PEG)

PEG is one of the most widely studied synthetic polymers in cell encapsulation due to its high water solubility, non-immunogenic response, low toxicity, and non-biodegradable property [54]. Various derivatives of PEG have been used to encapsulate cells for biomedical applications [55]. Gelation of PEG derivatives is initiated by either UV irradiation or simple redox reactions [80]. These polymers provide desirable mechanical strength and other properties for tissue engineering, but often lack biocompatibility necessary to support cell proliferation and differentiation [81]. To overcome this limitation, various efforts have been made to develop biocompatible derivatives with nontoxic natural polymers [66]. PEG-based scaffolds are capable of cell encapsulation and result in better predictive responses in testing efficacy and toxicity of breast cancer drugs, compared to conventional 2D cell monolayer approaches [82]. The crosslinking mechanisms of the hydrogels have been compared in Table 2.
Table
Table 2. Summary of hydrogels compatible for high-throughput cell printing and encapsulation.
Table 2. Summary of hydrogels compatible for high-throughput cell printing and encapsulation.
HydrogelGelation MechanismCompatible Cell LinesAdvantagesLimitations
AlginateCrosslinking via divalent ionsHuman adipose derived stem cells [61], human brain cancer cells [9]Good printability, applicable to stem cell growth [61], easy chemical modification [52]Non-supportive to viral transduction [26]
Matrigel®Temperature dependentHuman umbilical vein endothelial cells, colorectal cancer cells [63], rat cardiomyocytes [64]Applicable to differentiation, xenografts, spheroidal cell growth, 3D co-cultures [63]Clogging tips and solenoid valves due to temperature sensitive gelation
FibrinThrombin catalyzed polymerizationChondrocytes [57], rat myoblast [68]Applicable to tissue engineering, vascular grafts, gene delivery [35,47]Unstable due to degradation via MMPs [67]
Collagen (type 1)Temperature inducedEndothelial progenitor cells, mesenchymal progenitor cells [69]Applicable to tissue engineering [73]Unstable due to degradation via collagenases, clogging tips and valves [83]
HyaluroninThermal or photo dependent gelation [52]Mesenchymal stem cell [35], endothelial cells [37]Applicable to tissue engineering, regenerative medicine, stem cell differentiation, wound healing, angiogenesis [76]Poor mechanical strength
PuraMatrix™Self-assembling when exposed to saltsPrimary rat hepatocytes, adult liver progenitor cells, chondrocytes [79]Embryonic stem cell cultures [79]Poor cyto-compatibility due to low pH
PEGUV crosslinking, simple redox crosslinkingHuman mesenchymal stem cells [54]High mechanical strengthNo cell-matrix interaction

5. Summary

Microarray bioprinting is a promising high-throughput approach for miniaturized 3D cell cultures. The reduction in sample volume and the speed of printing hundreds of samples in a short period of time make this technology suitable for wide ranges of cell-based assays. The major concern however, is to find out appropriate hydrogel matrices for cell encapsulation which provide tunability of their physical and chemical properties while being relatively cost-effective. Natural hydrogels are preferred due to high biocompatibility, mild gelation, and flexibility for chemical modification. However, several limitations such as poor control over material properties and mechanical strength make these hydrogels inconvenient when high mechanical properties are desired. Synthetic hydrogels provide better control over physical and chemical properties, but their use can be limited due to lack of biocompatibility. The selection of an optimum hydrogel matrix depends on specific applications. With wide options for selecting suitable hydrogels for miniaturized 3D cell cultures, researchers can optimize gelation and cell culture conditions for microarray bioprinting.

Acknowledgments

We are grateful to the funding from the National Institutes of Health (NIEHS R01ES025779) and institutional funds from the Cleveland State University (Faculty Research Development).

Conflicts of Interest

Author declares no conflict of interest.

References

  1. Echeverria, V.; Meyvantsson, I.; Skoien, A.; Worzella, T.; Lamers, C.; Hayes, S. An automated high-content assay for tumor cell migration through 3-dimensional matrices. J. Biomol. Screen. 2010, 15, 1144–1151. [Google Scholar] [CrossRef] [PubMed]
  2. Celli, J.P.; Rizvi, I.; Blanden, A.R.; Massodi, I.; Glidden, M.D.; Pogue, B.W.; Hasan, T. An imaging-based platform for high-content, quantitative evaluation of therapeutic response in 3D tumour models. Sci. Rep. 2014, 4, 1–9. [Google Scholar] [CrossRef] [PubMed]
  3. Leung, B.M.; Moraes, C.; Cavnar, S.P.; Luker, K.E.; Luker, G.D.; Takayama, S. Microscale 3D Collagen Cell Culture Assays in Conventional Flat-Bottom 384-Well Plates. J. Lab. Autom. 2015, 20, 138–145. [Google Scholar] [CrossRef] [PubMed]
  4. Ruedinger, F.; Lavrentieva, A.; Blume, C.; Pepelanova, I.; Scheper, T. Hydrogels for 3D mammalian cell culture: A starting guide for laboratory practice. Appl. Microbiol. Biotechnol. 2015, 99, 623–636. [Google Scholar] [CrossRef] [PubMed]
  5. Miller, J.S.; Stevens, K.R.; Yang, M.T.; Baker, B.M.; Nguyen, D.-H.T.; Cohen, D.M.; Toro, E.; Chen, A.A.; Galie, P.A.; Yu, X.; et al. Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues. Nat. Mater. 2012, 11, 768–774. [Google Scholar] [CrossRef] [PubMed]
  6. Hsiao, A.Y.; Tung, Y.C.; Kuo, C.H.; Mosadegh, B.; Bedenis, R.; Pienta, K.J.; Takayama, S. Micro-ring structures stabilize microdroplets to enable long term spheroid culture in 384 hanging drop array plates. Biomed. Microdevices 2012, 14, 313–323. [Google Scholar] [CrossRef] [PubMed]
  7. Hirschhaeuser, F.; Menne, H.; Dittfeld, C.; West, J.; Mueller-Klieser, W.; Kunz-Schughart, L.A. Multicellular tumor spheroids: An underestimated tool is catching up again. J. Biotechnol. 2010, 148, 3–15. [Google Scholar] [CrossRef] [PubMed]
  8. Lee, M.Y.; Kumar, R.A.; Sukumaran, S.M.; Hogg, M.G.; Clark, D.S.; Dordick, J.S. Three-dimensional cellular microarray for high-throughput toxicology assays. Proc. Natl. Acad. Sci. USA 2008, 105, 59–63. [Google Scholar] [CrossRef] [PubMed]
  9. Lee, D.W.; Choi, Y.; Seo, Y.J.; Lee, M.Y.; Jeon, Y.; Ku, B.; Kim, S.; Yi, S.H.; Nam, D. High-Throughput Screening ( HTS) of Anticancer Drug Efficacy on a Micropillar/Microwell Chip Platform. Anal. Chem. 2014, 86, 535–542. [Google Scholar] [CrossRef] [PubMed]
  10. Lam, V.; Wakatsuki, T. Hydrogel tissue construct-based high-content compound screening. J. Biomol. Screen. 2011, 16, 120–128. [Google Scholar] [CrossRef] [PubMed]
  11. Chien, H.W.; Tsai, W.B.; Jiang, S. Direct cell encapsulation in biodegradable and functionalizable carboxybetaine hydrogels. Biomaterials 2012, 33, 5706–5712. [Google Scholar] [CrossRef] [PubMed]
  12. Lowe, S.B.; Tan, V.T.G.; Soeriyadi, A.H.; Davis, T.P.; Gooding, J.J. Synthesis and high-throughput processing of polymeric hydrogels for 3D cell culture. Bioconjug. Chem. 2014, 25, 1581–1601. [Google Scholar] [CrossRef] [PubMed]
  13. Tasoglu, S.; Demirci, U. Bioprinting for stem cell research. Trends Biotechnol. 2013, 31, 10–19. [Google Scholar] [CrossRef] [PubMed]
  14. Reingeisen, B.R.; Spargo, B.J.; Wu, P.K. Cell and Organ Printing; Springer Science & Business Media: New York, NY, USA, 2010. [Google Scholar]
  15. Dias, A.D.; Kingsley, D.M.; Corr, D.T. Recent advances in bioprinting and applications for biosensing. Biosensors 2014, 4, 111–136. [Google Scholar] [PubMed]
  16. Cui, X.; Boland, T.; D’Lima, D.D.; Lotz, M.K. Thermal inkjet printing in tissue engineering and regenerative medicine. Recent Pat. Drug Deliv. Formul. 2012, 6, 1–13. [Google Scholar] [CrossRef]
  17. Guillotin, B.; Souquet, A.; Catros, S.; Duocastella, M.; Pippenger, B.; Bellance, S.; Bareille, R.; Rémy, M.; Bordenave, L.; Amédée, J.; et al. Laser assisted bioprinting of engineered tissue with high cell density and microscale organization. Biomaterials 2010, 31, 7250–7256. [Google Scholar] [CrossRef] [PubMed]
  18. Catros, S.; Guillotin, B.; Bačáková, M.; Fricain, J. C.; Guillemot, F. Effect of laser energy, substrate film thickness and bioink viscosity on viability of endothelial cells printed by Laser-Assisted Bioprinting. Appl. Surf. Sci. 2011, 257, 5142–5147. [Google Scholar] [CrossRef]
  19. Devillard, R.; Pagès, E.; Correa, M.M.; Kériquel, V.; Rémy, M.; Kalisky, J.; Ali, M.; Guillotin, B.; Guillemot, F. Cell patterning by laser-assisted bioprinting. In Methods in Cell Biology; Elsevier: Amsterdam, Netherlands, 2014; Volume 119, pp. 159–174. [Google Scholar]
  20. Page, H.; Flood, P.; Reynaud, E.G. Three-dimensional tissue cultures: Current trends and beyond. Cell Tissue Res. 2013, 352, 123–131. [Google Scholar] [CrossRef] [PubMed]
  21. Lee, J.; Cuddihy, M.J.; Kotov, N.A. Three-dimensional cell culture matrices: State of the art. Tissue Eng. Part B Rev. 2008, 14, 61–86. [Google Scholar] [CrossRef] [PubMed]
  22. Fang, Y.; Frampton, J.P.; Raghavan, S.; Sabahi-Kaviani, R.; Luker, G.; Deng, C.X.; Takayama, S. Rapid Generation of Multiplexed Cell Cocultures Using Acoustic Droplet Ejection Followed by Aqueous Two-Phase Exclusion Patterning. Tissue Eng. Part C Methods 2012, 18, 647–657. [Google Scholar] [CrossRef] [PubMed]
  23. Demirci, U.; Montesano, G. Single cell epitaxy by acoustic picolitre droplets. Lab Chip 2007, 7, 1139–1145. [Google Scholar] [CrossRef] [PubMed]
  24. Guzmán, H.R.; Nguyen, D.X.; Khan, S.; Prausnitz, M.R. Ultrasound-mediated disruption of cell membranes. II. Heterogeneous effects on cells. J. Acoust. Soc. Am. 2001, 110, 597–606. [Google Scholar] [CrossRef] [PubMed]
  25. Nishiyama, Y.; Nakamura, M.; Henmi, C.; Yamaguchi, K.; Mochizuki, S.; Nakagawa, H.; Takiura, K. Development of a three-dimensional bioprinter: Construction of cell supporting structures using hydrogel and state-of-the-art inkjet technology. J. Biomech. Eng. 2009, 131, 1–6. [Google Scholar] [CrossRef] [PubMed]
  26. Kwon, S.J.; Lee, D.W.; Shah, D.; Ku, B.; Solanki, K.; Jessica, R.D.; Clark, C.S.; Dordick, J.S.; Lee, M.Y. High-throughput and combinatorial gene expression on a chip for metabolism-induced Toxicology Screening. Nat. Commun. 2014, 5. [Google Scholar] [CrossRef] [PubMed]
  27. Ringeisen, B.R.; Othon, C.M.; Barron, J.A.; Young, D.; Spargo, B.J. Jet-based methods to print living cells. Biotechnol. J. 2006, 1, 930–948. [Google Scholar] [CrossRef] [PubMed]
  28. Bertassoni, L.E.; Cardoso, J.C.; Manoharan, V.; Cristino, A.L.; Bhise, N.S.; Araujo, W.A.; Zorlutuna, P.; Vrana, N.E.; Ghaemmaghami, A.M.; Dokmeci, M.R.; et al. Direct-write bioprinting of cell-laden methacrylated gelatin hydrogels. Biofabrication 2014, 6, 1–11. [Google Scholar] [CrossRef] [PubMed]
  29. Raof, N.A.; Schiele, N.R.; Xie, Y.; Chrisey, D.B.; Corr, D.T. The maintenance of pluripotency following laser direct-write of mouse embryonic stem cells. Biomaterials 2011, 32, 1802–1808. [Google Scholar] [CrossRef] [PubMed]
  30. Mironov, V.; Kasyanov, V.; Markwald, R.R. Organ printing: From bioprinter to organ biofabrication line. Curr. Opin. Biotechnol. 2011, 22, 667–673. [Google Scholar] [CrossRef] [PubMed]
  31. Jin, R.; Dijkstra, P.J. Hydrogels for Tissue Engineering Applications. Biomed. Appl. Hydrog. Handb. 2010, 101, 203–225. [Google Scholar]
  32. Gevaert, E.; Dollé, L.; Billiet, T.; Dubruel, P.; van Grunsven, L.; van Apeldoorn, A.; Cornelissen, R. High Throughput Micro-Well Generation of Hepatocyte Micro-Aggregates for Tissue Engineering. PLoS ONE 2014, 9. [Google Scholar] [CrossRef] [Green Version]
  33. Fernandes, T.G.; Kwon, S.J.; Bale, S.S.; Lee, M.Y.; Diogo, M.M.; Clark, D.S.; Cabral, J.M.S.; Dordick, J.S. Three-dimensional cell culture microarray for high-throughput studies of stem cell fate. Biotechnol. Bioeng. 2010, 106, 106–118. [Google Scholar] [CrossRef] [PubMed]
  34. Kesti, M.; Müller, M.; Becher, J.; Schnabelrauch, M.; D’Este, M.; Eglin, D.; Zenobi-Wong, M. A versatile bioink for three-dimensional printing of cellular scaffolds based on thermally and photo-triggered tandem gelation. Acta Biomater. 2015, 11, 162–172. [Google Scholar] [CrossRef] [PubMed]
  35. Nicodemus, G.D.; Bryant, S.J. Cell encapsulation in biodegradable hydrogels for tissue engineering applications. Tissue Eng. Part B Rev. 2008, 14, 149–165. [Google Scholar] [CrossRef] [PubMed]
  36. Liu, J.; Song, H.; Zhang, L.; Xu, H.; Zhao, X. Self-assembly-peptide hydrogels as tissue-engineering scaffolds for three-dimensional culture of chondrocytes in vitro. Macromol. Biosci. 2010, 10, 1164–1170. [Google Scholar] [CrossRef] [PubMed]
  37. Seidlits, S.K.; Drinnan, C.T.; Petersen, R.R.; Shear, J.B.; Suggs, L.J.; Schmidt, C.E. Fibronectin-hyaluronic acid composite hydrogels for three-dimensional endothelial cell culture. Acta Biomater. 2011, 7, 2401–2409. [Google Scholar] [CrossRef] [PubMed]
  38. Peppas, N.A.; Bures, P.; Leobandung, W.; Ichikawa, H. Hydrogels in pharmaceutical formulations. Eur. J. Pharm. Biopharm. 2000, 50, 27–46. [Google Scholar] [CrossRef]
  39. Altunbas, A.; Lee, S.J.; Rajasekaran, S.A.; Schneider, J.P.; Pochan, D.J. Encapsulation of curcumin in self-assembling peptide hydrogels as injectable drug delivery vehicles. Biomaterials 2011, 32, 5906–5914. [Google Scholar] [CrossRef] [PubMed]
  40. Panzavolta, S.; Torricelli, P.; Amadori, S.; Parrilli, A.; Rubini, K.; Della Bella, E.; Fini, M.; Bigi, A. 3D interconnected porous biomimetic scaffolds: In vitro cell response. J. Biomed. Mater. Res. Part A 2013, 101, 3560–3570. [Google Scholar] [CrossRef] [PubMed]
  41. Drury, J.L.; Mooney, D.J. Hydrogels for tissue engineering: Scaffold design variables and applications. Biomaterials 2003, 24, 4337–4351. [Google Scholar] [CrossRef]
  42. Jeon, O.; Bouhadir, K.H.; Mansour, J.M.; Alsberg, E. Photocrosslinked alginate hydrogels with tunable biodegradation rates and mechanical properties. Biomaterials 2009, 30, 2724–2734. [Google Scholar] [CrossRef] [PubMed]
  43. Murphy, S.V.; Skardal, A.; Atala, A. Evaluation of hydrogels for bio-printing applications. J. Biomed. Mater. Res. A 2013, 101, 272–284. [Google Scholar] [CrossRef] [PubMed]
  44. Hoo, S.P.; Sarvi, F.; Li, W.H.; Chan, P.P.Y.; Yue, Z. Thermoresponsive cellulosic hydrogels with cell-releasing behavior. ACS Appl. Mater. Interfaces 2013, 5, 5592–5600. [Google Scholar] [CrossRef] [PubMed]
  45. Zhu, J.; Marchant, R.E. Design properties of hydrogel tissue-engineering scaffolds. Expert Rev. Med. Devices 2011, 8, 607–626. [Google Scholar] [CrossRef] [PubMed]
  46. Alépée, N.; Bahinski, A.; Daneshian, M.; de Wever, B.; Fritsche, E.; Goldberg, A.; Hansmann, J.; Hartung, T.; Haycock, J.; Hogberg, H.T.; et al. State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology. Altex 2014, 31, 441–464. [Google Scholar] [CrossRef] [PubMed]
  47. Zhang, Z.; He, Q.; Deng, W.; Chen, Q.; Hu, X.; Gong, A.; Cao, X.; Yu, J.; Xu, X. Biomaterials Nasal ectomesenchymal stem cells : Multi-lineage differentiation and transformation effects on fibrin gels. Biomaterials 2015, 49, 57–67. [Google Scholar] [CrossRef] [PubMed]
  48. Fernandes, T.G.; Kwon, S.J.; Lee, M.Y.; Clark, D.S.; Cabral, J.M.S.; Dordick, J.S. On-chip, cell-based microarray immunofluorescence assay for high-throughput analysis of target proteins. Anal. Chem. 2008, 80, 6633–6639. [Google Scholar] [CrossRef] [PubMed]
  49. Molinos, M.; Carvalho, V.; Silva, D.M.; Gama, F.M. Development of a hybrid dextrin hydrogel encapsulating dextrin nanogel as protein delivery system. Biomacromolecules 2012, 13, 517–527. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  50. Kunz-Schughart, L.A.; Freyer, J.P.; Hofstaedter, F.; Ebner, R. The use of 3-D cultures for high-throughput screening: The multicellular spheroid model. J. Biomol. Screen. 2004, 9, 273–285. [Google Scholar] [CrossRef] [PubMed]
  51. Ferrarini, M.; Steimberg, N.; Ponzoni, M.; Belloni, D.; Berenzi, A.; Girlanda, S.; Caligaris-Cappio, F.; Mazzoleni, G.; Ferrero, E. Ex-Vivo Dynamic 3-D Culture of Human Tissues in the RCCS™ Bioreactor Allows the Study of Multiple Myeloma Biology and Response to Therapy. PLoS ONE 2013, 8, 1–10. [Google Scholar]
  52. Gasperini, L.; Mano, J.F.; Reis, R.L. Natural polymers for the microencapsulation of cells. J. R. Soc. Interface 2014, 11. [Google Scholar] [CrossRef]
  53. Jonker, A.M.; Löwik, D.W.P.M.; van Hest, J.C.M. Peptide- and protein-based hydrogels. Chem. Mater. 2012, 24, 759–773. [Google Scholar] [CrossRef]
  54. Nuttelman, C.R.; Tripodi, M.C.; Anseth, K.S. Synthetic hydrogel niches that promote hMSC viability. Matrix Biol. 2005, 24, 208–218. [Google Scholar] [CrossRef] [PubMed]
  55. Gibas, I.; Janik, H. Review : Synthetic Polymer Hydrogels for Biomedical. Chem. Technol. 2010, 4, 297–304. [Google Scholar]
  56. Chawla, K.; Yu, T. Bin; Liao, S.W.; Guan, Z. Biodegradable and biocompatible synthetic saccharide-peptide hydrogels for three-dimensional stem cell culture. Biomacromolecules 2011, 12, 560–567. [Google Scholar] [CrossRef] [PubMed]
  57. Eyrich, D.; Brandl, F.; Appel, B.; Wiese, H.; Maier, G.; Wenzel, M.; Staudenmaier, R.; Goepferich, A.; Blunk, T. Long-term stable fibrin gels for cartilage engineering. Biomaterials 2007, 28, 55–65. [Google Scholar] [CrossRef] [PubMed]
  58. Guillouzo, A. Liver cell models in in vitro toxicology. Environ. Health Perspect. 1998, 106, 511–532. [Google Scholar] [CrossRef] [PubMed]
  59. Astashkina, A.; Grainger, D.W. Critical analysis of 3-D organoid in vitro cell culture models for high-throughput drug candidate toxicity assessments. Adv. Drug Deliv. Rev. 2014, 69, 1–18. [Google Scholar] [CrossRef] [PubMed]
  60. Chen, K.G.; Mallon, B.S.; McKay, R.D.G.; Robey, P.G. Human Pluripotent Stem Cell Culture: Considerations for Maintenance, Expansion, and Therapeutics. Cell Stem Cell 2014, 14, 13–26. [Google Scholar] [CrossRef] [PubMed]
  61. Jia, J.; Richards, D.J.; Pollard, S.; Tan, Y.; Rodriguez, J.; Visconti, R.P.; Trusk, T.C.; Yost, M.J.; Yao, H.; Markwald, R.R.; et al. Engineering alginate as bioink for bioprinting. Acta Biomater. 2014, 10, 4323–4331. [Google Scholar] [CrossRef] [PubMed]
  62. Orive, G.; Tam, S.; Pedraz, J.; Halle, J. Biocompatibility of alginate-poly-l-lysine microcapsules for cell therapy. Biomaterials 2006, 27, 3691–3700. [Google Scholar] [CrossRef] [PubMed]
  63. Benton, G.; Arnaoutova, I.; George, J.; Kleinman, H. K.; Koblinski, J. Matrigel: From discovery and ECM mimicry to assays and models for cancer research. Adv. Drug Deliv. Rev. 2014, 79, 3–18. [Google Scholar] [CrossRef] [PubMed]
  64. Morritt, A.N.; Bortolotto, S.K.; Dilley, R.J.; Han, X.; Kompa, A.R.; McCombe, D.; Wright, C.E.; Itescu, S.; Angus, J.A.; Morrison, W.A. Cardiac tissue engineering in an in vivo vascularized chamber. Circulation 2007, 115, 353–360. [Google Scholar] [CrossRef] [PubMed]
  65. Ponce, M.L. Tube Formation: An In Vitro Matrigel Angiogenesis Assay. Angiogenes. Protoc. 2009, 467, 183–188. [Google Scholar]
  66. Thiele, J.; Ma, Y.; Bruekers, S.M.C.; Ma, S.; Huck, W.T.S. 25th anniversary article: Designer hydrogels for cell cultures: A materials selection guide. Adv. Mater. 2014, 26, 125–148. [Google Scholar] [CrossRef] [PubMed]
  67. Luyckx, V.; Dolmans, M.-M.; Vanacker, J.; Scalercio, S.R.; Donnez, J.; Amorim, C.A. First step in developing a 3D biodegradable fibrin scaffold for an artificial ovary. J. Ovarian Res. 2013, 6, 1–10. [Google Scholar] [CrossRef] [PubMed]
  68. Huang, Y.C.; Dennis, R.G.; Larkin, L.; Baar, K. Rapid formation of functional muscle in vitro using fibrin gels. J. Appl. Physiol. 2005, 98, 706–713. [Google Scholar] [CrossRef] [PubMed]
  69. Allen, P.; Melero-martin, J.; Bischoff, J. Type I collagen, fibrin and PuraMatrix matrices provide permissive environments for human endothelial and mesenchymal progenitor cells to form neovascular networks. J. Tissue Eng. Reger. Med. 2011, 5, 74–86. [Google Scholar] [CrossRef] [PubMed]
  70. Spencer, N.J.; Cotanche, D.A.; Klapperich, C.M. Peptide- and collagen-based hydrogel substrates for in vitro culture of chick cochleae. Biomaterials 2008, 29, 1028–1042. [Google Scholar] [CrossRef] [PubMed]
  71. Tibbitt, M.W.; Anseth, K.S. Hydrogels as Extracelluar Matrix Mimics for 3D Cell Culture. Biotechnol. Bioeng. 2009, 103, 655–663. [Google Scholar] [CrossRef] [PubMed]
  72. Wolf, M.T.; Daly, K.A.; Brennan-Pierce, E.P.; Johnson, S.A.; Carruthers, C.A.; D’Amore, A.; Nagarkar, S.P.; Velankar, S.S.; Badylak, S.F. A hydrogel derived from decellularized dermal extracellular matrix. Biomaterials 2012, 33, 7028–7038. [Google Scholar] [CrossRef] [PubMed]
  73. Rubert, P.C.M.; Panitch, A.; Chmielewski, J. A collagen peptide-based physical hydrogel for cell encapsulation. Macromol. Biosci. 2011, 11, 1426–1431. [Google Scholar] [CrossRef] [PubMed]
  74. Smith, M.M.; Russell, A.K.; Schiavinato, A.; Little, C.B. A hexadecylamide—Derivative of hyaluronan (HYMOVIS(R)) has superior beneficial effects on human osteoarthritic chondrocytes and synoviocytes than unmodified hyaluronan. J. Inflamm. Lond. 2013, 10, 1–16. [Google Scholar] [CrossRef] [PubMed]
  75. Laurens, E.; Schneider, E.; Calabro, A. A synthetic cartilage extracellular matrix model: Hyaluronan and collagen hydrogel relaxivity, impact of macromolecular concentration on dGEMRIC. Skelet. Radiol. 2012, 41, 209–217. [Google Scholar] [CrossRef] [PubMed]
  76. Serban, M.A.; Scott, A.; Prestwich, G.D. Use of Hyaluronan-Derived Hydrogels for Three-Dimensional Cell Culture and Tumor Xenografts. Curr. Protoc. Cell Biol. 2008, 10, 1–10. [Google Scholar]
  77. Chin, L.; Calabro, A.; Walker, E.; Derwin, K. Mechanical properties of tyramine substituted-hyaluronan enriched fascia extracellular matrix. J. Biomed. Mater. Res. Part A 2012, 100, 786–793. [Google Scholar] [CrossRef] [PubMed]
  78. Bulpitt, P.; Aeschlimann, D. New strategy for chemical modification of hyaluronic acid: Preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels. J. Biomed. Mater. Res. 1999, 47, 152–169. [Google Scholar] [CrossRef]
  79. Zhang, S.; Ellis-behnke, R.; Zhao, X. PuraMatrix : Self-assembling Peptide Nanofiber Scaffolds. In Scaffolding in Tissue Engineering; CRC press: Boca Raton, FL, USA, 2005; pp. 217–238. [Google Scholar]
  80. Park, M.H.; Moon, H.J.; Park, J.H.; Shinde, U.P.; Ko, D.Y.; Jeong, B. PEG-Poly(l-alanine) thermogel as a 3D scaffold of bone-marrow-derived mesenchymal stem cells. In Macromolecular Bioscience; WILEY-VCH Verlag GmbH & Co. KGaA: Weinheim, Germany, 2014; Volume 15, pp. 464–472. [Google Scholar]
  81. Lee, B.H.; Kim, M.H.; Lee, J.H.; Seliktar, D.; Cho, N.-J.; Tan, L.P. Modulation of Huh7.5 Spheroid Formation and Functionality Using Modified PEG-Based Hydrogels of Different Stiffness. PLoS ONE 2015, 10, 1–20. [Google Scholar] [CrossRef] [PubMed]
  82. Håkanson, M.; Kobel, S.; Lutolf, M.P.; Textor, M.; Cukierman, E.; Charnley, M. Controlled breast cancer microarrays for the deconvolution of cellular multilayering and density effects upon drug responses. PLoS ONE 2012, 7, 1–12. [Google Scholar] [CrossRef] [PubMed]
  83. Friedl, P.; Wolf, K. Tumour-cell invasion and migration: Diversity and escape mechanisms. Nat. Rev. Cancer 2003, 3, 362–374. [Google Scholar] [CrossRef] [PubMed]

Share and Cite

MDPI and ACS Style

Datar, A.; Joshi, P.; Lee, M.-Y. Biocompatible Hydrogels for Microarray Cell Printing and Encapsulation. Biosensors 2015, 5, 647-663. https://doi.org/10.3390/bios5040647

AMA Style

Datar A, Joshi P, Lee M-Y. Biocompatible Hydrogels for Microarray Cell Printing and Encapsulation. Biosensors. 2015; 5(4):647-663. https://doi.org/10.3390/bios5040647

Chicago/Turabian Style

Datar, Akshata, Pranav Joshi, and Moo-Yeal Lee. 2015. "Biocompatible Hydrogels for Microarray Cell Printing and Encapsulation" Biosensors 5, no. 4: 647-663. https://doi.org/10.3390/bios5040647

Article Metrics

Back to TopTop